Transamerica Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $321K | Sell |
638
-7,922
| -93% | -$3.8M | 0.03% | 353 |
|
|
2026
Q1 | $4.21M | Sell |
8,560
-319
| -4% | -$173K | 0.36% | 69 |
|
|
2025
Q4 | $5.15M | Buy |
8,879
+2,615
| +42% | +$1.48M | 0.43% | 65 |
|
|
2025
Q3 | $3.04M | Sell |
6,264
-59
| -0.9% | -$27.5K | 0.25% | 86 |
|
|
2025
Q2 | $2.56M | Sell |
6,323
-79
| -1% | -$33K | 0.24% | 94 |
|
|
2025
Q1 | $3.19M | Sell |
6,402
-136
| -2% | -$73.7K | 0.33% | 78 |
|
|
2024
Q4 | $3.4M | Sell |
6,538
-177
| -3% | -$97.3K | 0.34% | 78 |
|
|
2024
Q3 | $4.15M | Buy |
6,715
+6,599
| +5,689% | +$3.91M | 0.41% | 70 |
|
|
2024
Q2 | $64K | Hold |
116
| – | – | 0.01% | 268 |
|
|
2024
Q1 | $68K | Sell |
116
-444
| -79% | -$249K | 0.01% | 289 |
|
|
2023
Q4 | $297K | Sell |
560
-182
| -25% | -$88.1K | 0.04% | 218 |
|
|
2023
Q3 | $376K | Sell |
742
-97
| -12% | -$51.7K | 0.05% | 179 |
|
|
2023
Q2 | $438K | Sell |
839
-3
| -0.4% | -$1.62K | 0.06% | 185 |
|
|
2023
Q1 | $486K | Buy |
842
+311
| +59% | +$175K | 0.06% | 179 |
|
|
2022
Q4 | $293K | Sell |
531
-11
| -2% | -$5.83K | 0.04% | 196 |
|
|
2022
Q3 | $275K | Buy |
542
+8
| +1% | +$4.48K | 0.04% | 192 |
|
|
2022
Q2 | $291K | Buy |
+534
| New | +$294K | 0.04% | 198 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | -$1K | – | 196 |
|
|
2021
Q2 | $1K | Hold |
1
| – | – | 0.02% | 186 |
|
|
2021
Q1 | $1K | Hold |
1
| – | – | 0.02% | 185 |
|
|
2020
Q4 | $1K | Hold |
1
| – | – | 0.02% | 179 |
|
|
2020
Q3 | $1K | Sell |
1
-240
| -100% | -$99.2K | 0.02% | 176 |
|
|
2020
Q2 | $87K | Buy |
+241
| New | +$80.8K | 0.02% | 191 |
|
|
2019
Q3 | – | Sell |
-197
| Closed | -$58K | – | 480 |
|
|
2019
Q2 | $58K | Buy |
+197
| New | +$54.3K | 0.01% | 244 |
|
|
2019
Q1 | – | Sell |
-210
| Closed | -$47K | – | 419 |
|
|
2018
Q4 | $47K | Sell |
210
-68
| -24% | -$16K | 0.01% | 212 |
|
|
2018
Q3 | $68K | Sell |
278
-18
| -6% | -$4.14K | 0.01% | 210 |
|
|
2018
Q2 | $62K | Sell |
296
-3,379
| -92% | -$717K | 0.01% | 221 |
|
|
2018
Q1 | $759K | Sell |
3,675
-185
| -5% | -$38.8K | 0.11% | 152 |
|
|
2017
Q4 | $733K | Sell |
3,860
-24
| -0.6% | -$4.6K | 0.1% | 165 |
|
|
2017
Q3 | $735K | Sell |
3,884
-58
| -1% | -$10.5K | 0.09% | 157 |
|
|
2017
Q2 | $688K | Sell |
3,942
-1
| -0% | -$168 | 0.09% | 149 |
|
|
2017
Q1 | $606K | Buy |
3,943
+4
| +0.1% | +$611 | 0.07% | 179 |
|
|
2016
Q4 | $556K | Buy |
3,939
+31
| +0.8% | +$4.57K | 0.07% | 178 |
|
|
2016
Q3 | $622K | Buy |
3,908
+322
| +9% | +$49.6K | 0.07% | 184 |
|
|
2016
Q2 | $530K | Buy |
3,586
+1,270
| +55% | +$187K | 0.05% | 189 |
|
|
2016
Q1 | $328K | Sell |
2,316
-7,778
| -77% | -$1.04M | 0.03% | 265 |
|
|
2015
Q4 | $1.43M | Buy |
10,094
+497
| +5% | +$66.3K | 0.11% | 147 |
|
|
2015
Q3 | $1.17M | Sell |
9,597
-4,531
| -32% | -$590K | 0.09% | 144 |
|
|
2015
Q2 | $1.83M | Buy |
14,128
+1,312
| +10% | +$171K | 0.13% | 125 |
|
|
2015
Q1 | $1.72M | Sell |
12,816
-7,910
| -38% | -$1.02M | 0.12% | 138 |
|
|
2014
Q4 | $2.6M | Buy |
+20,726
| New | +$2.52M | 0.2% | 68 |
|
Other funds holding TMO
Transamerica Financial Advisors's TMO Position: Q2 2026 in Review
Transamerica Financial Advisors reduced its Thermo Fisher Scientific (TMO) stake by 93% in Q2 2026, selling an estimated $3.8M and leaving 638 shares worth $321K. The position accounts for 0.03% of the portfolio, ranked #353.
Transamerica Financial Advisors first reported a position in TMO in Q4 2014 and has held it in 40 quarters since. The position peaked at $5.15M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Transamerica Financial Advisors held 638 shares of Thermo Fisher Scientific worth $321K as of Q2 2026.
- Transamerica Financial Advisors sold 7,922 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.8M.
- Thermo Fisher Scientific made up 0.03% of Transamerica Financial Advisors's portfolio in Q2 2026, its #353 holding.
- Transamerica Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 40 quarters since.
- Transamerica Financial Advisors's Thermo Fisher Scientific position peaked at $5.15M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.